JC

Jagadev Chaudhari

Active Director Additional Director DIN 08190811
DIN 08190811 First appointment Jul 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Jagadev Chaudhari

Data last updated:

Jagadev Chaudhari is an Additional Director at Sikitsa Healthcare Private Limited (since 2018). The company operates in Healthcare.

DIN 08190811
Primary Designation Additional Director
Industry Healthcare
First Appointment 30 Jul 2018
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sikitsa Healthcare Private Limited U85190DL2016PTC301500
Additional Director30 Jul 20182016Active

Board colleagues of Jagadev Chaudhari

NameDINCompanyDesignation
Ansh Kumar Chopra07522657Sikitsa Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sikitsa Healthcare Private Limited
Premium access

Shareholding and investment profile for Jagadev Chaudhari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagadev Chaudhari

Jagadev Chaudhari currently holds 1 directorship: Sikitsa Healthcare Private Limited (Additional Director, since 30 Jul 2018).

Jagadev Chaudhari was first appointed on 30 Jul 2018 as Additional Director at Sikitsa Healthcare Private Limited.

The current boards of Jagadev Chaudhari's companies include Ansh Kumar Chopra (Sikitsa Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available